HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Masahide Matsuda Selected Research

Therapeutics

12/2021Peritumoral edema status of glioblastoma identifies patients reaching long-term disease control with specific progression patterns after tumor resection and high-dose proton boost.
12/2021Safety and efficacy of depatuxizumab mafodotin in Japanese patients with malignant glioma: A nonrandomized, phase 1/2 trial.
1/2021Hemagglutinating virus of Japan-envelope containing programmed cell death-ligand 1 siRNA inhibits immunosuppressive activities and elicits antitumor immune responses in glioma.
4/2020Infiltration of CD163-positive macrophages in glioma tissues after treatment with anti-PD-L1 antibody and role of PI3Kγ inhibitor as a combination therapy with anti-PD-L1 antibody in in vivo model using temozolomide-resistant murine glioma-initiating cells.
7/2018Potential use of prostate specific membrane antigen (PSMA) for detecting the tumor neovasculature of brain tumors by PET imaging with 89Zr-Df-IAB2M anti-PSMA minibody.
4/2018MyD88 Mutation in Elderly Predicts Poor Prognosis in Primary Central Nervous System Lymphoma: Multi-Institutional Analysis.
6/2017[Combination Therapy with Radiation, Temozolomide, and Bevacizumab after Partial Tumor Removal in Glioblastoma Patients with Low Performance Status].
6/2017Efficacy of bevacizumab therapy in recurrent malignant gliomas in relation to the prior recurrence pattern or tumor location.
2/2017The anti-angiogenic role of soluble-form VEGF receptor in malignant gliomas.
11/2016Combination of Palonosetron, Aprepitant, and Dexamethasone Effectively Controls Chemotherapy-induced Nausea and Vomiting in Patients Treated with Concomitant Temozolomide and Radiotherapy: Results of a Prospective Study.
For more, sign up at right for free...

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Masahide Matsuda Research Topics

Disease

32Neoplasms (Cancer)
04/2022 - 10/2008
22Glioma (Gliomas)
04/2022 - 04/2010
19Glioblastoma (Glioblastoma Multiforme)
12/2021 - 04/2009
8Brain Neoplasms (Brain Tumor)
05/2022 - 01/2009
5Astrocytoma (Pilocytic Astrocytoma)
01/2020 - 04/2011
4Edema (Dropsy)
12/2021 - 01/2009
4Germinoma
01/2021 - 01/2012
4Brain Edema (Cerebral Edema)
07/2017 - 01/2009
3Oligodendroglioma
10/2020 - 04/2011
2Necrosis
07/2018 - 10/2016
2Lymphoma (Lymphomas)
04/2018 - 11/2015
2Inflammation (Inflammations)
02/2018 - 01/2013
2Vomiting
11/2016 - 01/2015
2Nausea
11/2016 - 01/2015
2Hemorrhage
07/2015 - 01/2013
1Hydrocephalus (Hydrocephaly)
10/2022
1Status Epilepticus (Complex Partial Status Epilepticus)
05/2022
1Seizures (Absence Seizure)
05/2022
1Epilepsy (Aura)
05/2022
1Venous Thrombosis (Deep-Vein Thrombosis)
04/2022
1Headache (Headaches)
02/2022
1Spasm (Spasms)
02/2022
1Thrombocytopenia (Thrombopenia)
12/2021
1Lymphopenia (Lymphocytopenia)
12/2021
1Diabetes Insipidus
01/2021
1Germ Cell and Embryonal Neoplasms (Germ Cell Tumor)
01/2021
1Abducens Nerve Diseases (Sixth Nerve Palsy)
01/2020
1Hypesthesia (Numbness)
01/2020
1Residual Neoplasm
01/2020
1Neurologic Manifestations (Neurological Manifestations)
07/2018
1Encephalocele (Encephalocele, Frontal)
07/2018
1Cysts
06/2018
1Central Nervous System Diseases (CNS Diseases)
02/2018
1Diplopia (Double Vision)
02/2018
1Epidural Abscess
07/2017
1Meningioma (Meningiomas)
05/2016
1Hemangiosarcoma (Angiosarcoma)
01/2016
1Pituitary Neoplasms (Pituitary Adenoma)
01/2016
1Paralysis (Palsy)
10/2015
1Hematoma
07/2015
1Acoustic Neuroma (Acoustic Neurinoma)
07/2015

Drug/Important Bio-Agent (IBA)

11Temozolomide (Temodar)FDA LinkGeneric
12/2021 - 01/2014
7Bevacizumab (Avastin)FDA Link
07/2018 - 01/2013
4Isocitrate Dehydrogenase (Isocitrate Dehydrogenase (NAD+))IBA
10/2020 - 04/2011
4GadoliniumIBA
07/2018 - 10/2008
3CytokinesIBA
07/2020 - 05/2011
3Carmustine (FIVB)FDA Link
06/2018 - 07/2014
3Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA
02/2017 - 01/2014
3AcidsIBA
01/2017 - 01/2009
2ErbB Receptors (EGF Receptor)IBA
12/2021 - 08/2014
2LigandsIBA
01/2021 - 06/2017
2Tumor Biomarkers (Tumor Markers)IBA
01/2021 - 01/2021
2Small Interfering RNA (siRNA)IBA
01/2021 - 03/2014
2AntigensIBA
07/2018 - 01/2012
2SteroidsIBA
02/2018 - 01/2013
2Talaporfin (talaporfin sodium)IBA
01/2017 - 01/2009
2AntiemeticsIBA
11/2016 - 01/2015
2EmeticsIBA
11/2016 - 01/2015
2InterferonsIBA
11/2014 - 04/2010
1Sodium Channel BlockersIBA
05/2022
1Levetiracetam (Keppra)FDA LinkGeneric
05/2022
1fibrin fragment D (D-dimer)IBA
04/2022
1Protons (Proton)IBA
12/2021
1Alanine Transaminase (SGPT)IBA
12/2021
1depatuxizumab mafodotinIBA
12/2021
1Aspartate Aminotransferases (Aspartate Transaminase)IBA
12/2021
1Immunoconjugates (Immunoconjugate)IBA
12/2021
1Telomerase (Telomerase Reverse Transcriptase)IBA
10/2020
1Immune Checkpoint InhibitorsIBA
07/2020
1ChemokinesIBA
07/2020
1Immune Checkpoint ProteinsIBA
07/2020
1IPI-549IBA
04/2020
1Reticulin (Reticular Fiber)IBA
01/2020
1Interleukin-2 Receptors (IL 2 Receptor)IBA
01/2019
189Zr-Df-IAB2MIBA
07/2018
1Genetic Markers (Genetic Marker)IBA
04/2018
1Biomarkers (Surrogate Marker)IBA
06/2017
1Vascular Endothelial Growth Factor Receptors (VEGF Receptors)IBA
02/2017
1Proteins (Proteins, Gene)FDA Link
02/2017
1Dexamethasone (Maxidex)FDA LinkGeneric
11/2016
1Aprepitant (Emend)FDA Link
11/2016
1Palonosetron (Aloxi)FDA Link
11/2016
1NimustineIBA
10/2016
1poliferprosan 20 drug combination carmustine (Gliadel)FDA Link
07/2016
1Aminolevulinic Acid (Levulan)FDA Link
01/2016
1Thorium Dioxide (Thorotrast)IBA
01/2016
1AntibodiesIBA
07/2015

Therapy/Procedure

16Therapeutics
12/2021 - 05/2011
13Radiotherapy
10/2022 - 07/2009
10Drug Therapy (Chemotherapy)
10/2022 - 04/2010
4Craniotomy
05/2022 - 10/2015
4Microvascular Decompression Surgery
02/2022 - 10/2015
4Chemoradiotherapy
12/2021 - 01/2015
3Immunotherapy
07/2021 - 04/2020
2Proton Therapy
01/2020 - 10/2016
1Craniospinal Irradiation
01/2021
1Aftercare (After-Treatment)
04/2020
1Decompressive Craniectomy
07/2018
1Salvage Therapy
07/2018
1Neoadjuvant Therapy
09/2015